These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2815272)

  • 1. The effects of deoxyspergualin on human lymphocyte proliferation in vitro.
    Kerr PG; Atkins RC
    Transplant Proc; 1989 Oct; 21(5):3765-6. PubMed ID: 2815272
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of deoxyspergualin on lymphocytes and monocytes in vivo and in vitro.
    Kerr PG; Atkins RC
    Transplantation; 1989 Dec; 48(6):1048-52. PubMed ID: 2531949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of IL-2 and IL-4 with the effects of deoxyspergualin.
    Kerr PG; Atkins RC
    Transplant Proc; 1990 Oct; 22(5):2121-2. PubMed ID: 2219316
    [No Abstract]   [Full Text] [Related]  

  • 4. FK 506 and deoxyspergualin: additive immunosuppressive effect on rat cardiac allograft rejection in vivo and mitogen-stimulated human lymphocyte responses in vitro.
    Jiang H; Takahara S; Li D; Namiki M; Ishibashi M; Okuyama A; Sonoda T
    Transplant Proc; 1994 Aug; 26(4):2313-6. PubMed ID: 7520631
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro immunosuppressive effect of deoxymethylspergualin.
    Jiang H; Takahara S; Takano Y; Machida M; Iwasaki A; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Sonoda T
    Transplant Proc; 1990 Aug; 22(4):1633-7. PubMed ID: 2143857
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined immunosuppressive effect of FK 506 and other immunosuppressive agents on PHA- and CD3-stimulated human lymphocyte proliferation in vitro.
    Jiang H; Suguo H; Takahara S; Takano Y; Li D; Kameoka H; Moutabarrik A; Kokado Y; Ishibashi M; Okuyama A
    Transplant Proc; 1991 Dec; 23(6):2933-6. PubMed ID: 1721317
    [No Abstract]   [Full Text] [Related]  

  • 7. 15-Deoxyspergualin (a new guanidine-like drug) blocks T lymphocyte proliferation.
    Falk W; Ulrichs K; Müller-Ruchholtz W
    Transplant Proc; 1987 Oct; 19(5):4239-40. PubMed ID: 2960051
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of 15-deoxyspergualine on antigen-specific lymphocyte activation measured by CD69 expression.
    Maitre N; Goust JM
    Clin Immunol Immunopathol; 1997 Oct; 85(1):109-11. PubMed ID: 9325077
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunosuppressant deoxyspergualin inhibits antigen processing in monocytes.
    Hoeger PH; Tepper MA; Faith A; Higgins JA; Lamb JR; Geha RS
    J Immunol; 1994 Nov; 153(9):3908-16. PubMed ID: 7930603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of a xenogeneic mixed lymphocyte endothelial cell culture with 15-deoxyspergualin.
    Haisch CE; Lodge PA; Lamoureux C; Thomas FT
    Transplant Proc; 1992 Apr; 24(2):439-40. PubMed ID: 1566379
    [No Abstract]   [Full Text] [Related]  

  • 11. 15-Deoxyspergualin, a novel immunosuppressive drug: studies of the mechanism of action.
    Tepper MA; Nadler S; Mazzucco C; Singh C; Kelley SL
    Ann N Y Acad Sci; 1993 Jun; 685():136-47. PubMed ID: 8363218
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro immunosuppressive effect: a comparative study between deoxymethylspergualin and cyclosporin A, on human lymphocyte responses.
    Jiang H; Takahara S; Kokado Y; Ishibashi M; Sonoda T
    J Clin Lab Immunol; 1990 Oct; 33(2):75-81. PubMed ID: 1967069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies on the immunosuppressive activity of FK506, 15-deoxyspergualin, and cyclosporine.
    Ochiai T; Nakajima K; Sakamoto K; Nagata M; Gunji Y; Asano T; Isono K; Sakamaki T; Hamaguchi K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):829-32. PubMed ID: 2468228
    [No Abstract]   [Full Text] [Related]  

  • 14. Flow cytometric analysis of graft-infiltrating lymphocytes in deoxyspergualin-treated rat renal transplants.
    Takeuchi I; Chikaraishi T; Kanagawa K; Tanda K; Seki T; Togashi M; Koyanagi T
    Transplant Proc; 1994 Aug; 26(4):1905-6. PubMed ID: 8066620
    [No Abstract]   [Full Text] [Related]  

  • 15. Deoxyspergualin. Mechanism of action studies of a novel immunosuppressive drug.
    Tepper MA
    Ann N Y Acad Sci; 1993 Nov; 696():123-32. PubMed ID: 8109823
    [No Abstract]   [Full Text] [Related]  

  • 16. 15-Deoxyspergualin is a more potent and effective immunosuppressant than cyclosporine but does not effectively suppress lymphoproliferation in vivo.
    Yuh DD; Morris RE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):535-9. PubMed ID: 1990605
    [No Abstract]   [Full Text] [Related]  

  • 17. Cimetidine modulation of lymphocytes from renal allograft recipients.
    Gifford RR; Schmidtke JR; Ferguson RM
    Transplant Proc; 1981 Mar; 13(1 Pt 1):663-7. PubMed ID: 6455809
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphocyte activation mechanisms and in vitro actions of immunosuppressive drugs: a comparison.
    Dupont E; Denys C; Schandene L; Pereleux A; Romasco F; Wybran J
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1227-9. PubMed ID: 3152625
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunosuppressive mechanism of action of deoxymethylspergualin--a human in vitro assay.
    Takano Y; Takahara S; Jiang H; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Okuyama A
    Transplant Proc; 1992 Aug; 24(4):1372-4. PubMed ID: 1386697
    [No Abstract]   [Full Text] [Related]  

  • 20. 15-Deoxyspergualin inhibits nitric oxide production in the BB/W rat: mechanism for inhibition of islet cell dysfunction in diabetes and transplantation.
    Stevens RB; Lokeh A; Ansite JD; Rossini TJ; Sutherland DE; Mills CD
    Transplant Proc; 1994 Dec; 26(6):3370. PubMed ID: 7527968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.